Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart and hypertension.

R Fogari1, A Zoppi

  • 1Department of Internal Medicine and Therapeutics, University of Pavia, Italy.

American Journal of Hypertension
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Hypertension causes cardiac issues like left ventricular hypertrophy (LVH) and coronary atherosclerosis. Antihypertensive drugs help with heart failure from LVH but not coronary events, highlighting complex cardiovascular disease mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age affects the perception of limb length discrepancy in patients with and without a total hip arthroplasty.

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2017
Same author

Wavelength dispersion of the local field intensity in silver-gold nanocages.

Physical chemistry chemical physics : PCCP·2015
Same author

Functionalized Au/Ag nanocages as a novel fluorescence and SERS dual probe for sensing.

Journal of colloid and interface science·2013
Same author

Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2011
Same author

Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2010
Same journal

Hemodynamic Evolution of Heart Failure from Hypertension: Lower Stroke Volume Index and Higher Heart Rate.

American journal of hypertension·2026
Same journal

Opposite Seasonal Variation in Nighttime and Morning Blood Pressure: A Longitudinal Study of Patients with Hypertension.

American journal of hypertension·2026
Same journal

Screening for Postprandial Hypotension: The Importance of Home Blood Pressure Monitoring.

American journal of hypertension·2026
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
Same journal

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

American journal of hypertension·2026
Same journal

Estimated Pulse Wave Velocity Predicts Outcomes After Acute Ischemic Stroke: A Multinational Cohort Analysis.

American journal of hypertension·2026
See all related articles

Area of Science:

  • Cardiology
  • Hypertension Research
  • Molecular Cardiology

Background:

  • Hypertension leads to cardiac involvement, including hypertensive heart disease (left ventricular hypertrophy) and coronary atherosclerosis complications.
  • Antihypertensive treatment effectively reduces heart failure incidence but shows limited efficacy in preventing coronary events.
  • While elevated blood pressure is a primary stimulus for cardiac hypertrophy, neurohumoral factors also significantly modulate left ventricular hypertrophy development.

Purpose of the Study:

  • To explore the mechanisms of cardiac involvement in hypertension.
  • To differentiate the direct effects of blood pressure from other risk factors in cardiac complications.
  • To investigate the molecular basis of changes in myocardial contractility during hypertensive cardiac hypertrophy.

Related Experiment Videos

Main Methods:

  • Review of established knowledge on hypertensive heart disease and coronary atherosclerosis.
  • Analysis of factors influencing left ventricular hypertrophy development beyond blood pressure.
  • Examination of morphological and molecular changes in hypertrophied cardiac muscle, including myosin isoenzymes and ATPase activity.

Main Results:

  • Left ventricular hypertrophy is a key cardiac manifestation of hypertension, distinct from coronary complications.
  • Antihypertensive therapy impacts heart failure but not coronary events, suggesting different underlying pathways.
  • While experimental models show myosin isoenzymatic shifts, these are not consistently observed in humans; decreased myofibril ATPase activity is noted in human hypertrophied ventricles.

Conclusions:

  • Hypertension-induced cardiac hypertrophy and coronary atherosclerosis have distinct pathophysiological pathways and responses to treatment.
  • The molecular basis for altered cardiac contractility in human hypertensive hearts remains unclear.
  • Further research is needed to elucidate the role of neurohumoral factors and the precise molecular mechanisms driving cardiac changes in hypertension.